Venapax
Payments companies reported to CMS as associated with Venapax. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Venapax, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Venapax
These are the largest totals companies reported as associated with Venapax. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Petrides | Neptune, NJ | Surgical | $14,498.18 |
| Michael Sullivan | Sarasota, FL | Surgical | $12,597.69 |
| Andrew Gardner | Poughkeepsie, NY | Surgical | $6,006.81 |
| Julian Luetmer | Saint Cloud, MN | Surgical | $2,698.08 |
| Katie Hegdahl | Saint Cloud, MN | Adult Health (Nurse Practitioner) | $2,136.19 |
| Michael Kaiser | Westwood, KS | Surgical | $2,008.45 |
| Edward Hahm | Palo Alto, CA | Physician Assistant | $1,935.42 |
| Christine Hahm | San Francisco, CA | Surgical | $1,509.94 |
| Ed Cueto | Washington, DC | $1,478.44 | |
| Kyle Brinson | Indianapolis, IN | Physician Assistant | $1,449.23 |
Prescribed Venapax?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.